ASX:VFYPharmaceuticals, Biotechnology & Life SciencesLife Sciences Tools & Services
Vitrafy Life Sciences Ltd
$3.800
$0.230 (5.71%)
Day Range
$3.800 – $4.170
52 Week Range
$1.160 – $4.660
Volume
67.34K
Avg Volume (10D)
101.11K
Market Cap
$236.88M
Price Chart
OHLC · volume · moving averages
$3.800+$2.070 (+119.65%)over 6M
Hi$4.660Lo$1.555Avg Vol57.8K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$4.080
Previous Close
$4.030
Day High
$4.170
Day Low
$3.800
52 Week High
$4.660
52 Week Low
$1.160
Valuation
Fundamental multiples
Market Cap
236.88M
Shares Outstanding
62.34M
Price to Book
7.39
Trading Activity
Volume & order book
Volume
67.34K
Value Traded
269.58K
Bid
$3.800 × 316
Ask
$3.890 × 200
Performance
Returns across timeframes
1 Day
-1.71%
5 Day
-12.96%
13 Week
52.08%
52 Week
176.03%
YTD
214.84%
Technical Indicators
Momentum & moving averages
RSI (14)
50.08
50-Day SMA
$3.368
200-Day SMA
$2.235
— From the desk
Latest News
Biotechnology
Vitrafy Life Sciences Raising $30m to Scale Guardion Production and US Expansion
Vitrafy Life Sciences raises $30m to scale Guardion production and accelerate US expansion amid US blood market demand.
Biotechnology
Vitrafy Life Sciences Strikes US Partnership to Promote Cryopreservation Ecosystem for Red Blood Cells
Vitrafy inks US Vitalant pact to deploy next-gen cryopreservation for red blood cells as glycerol tech ends by 2027; signals early market traction.
Biotechnology
Vitrafy Life Sciences Reports Strong US Army Platelet Preservation Results
Vitrafy Life Sciences announces 94% post-thaw platelet recovery with 3% DMSO no-wash protocol, independent validation for frozen platelets.